Lactone-to-lactam editing alters the pharmacology of bilobalide

September 23, 2024·
Xiaoding Jiang
,
Xu He
,
Jonathan Wong
Stephan Scheeff
Stephan Scheeff
,
Sam Chun-Kit Hau
,
Tak Hin Wong
,
Yao Qin
,
Chi Hang Fan
,
Bowen Ma
,
Ngai Lam Chung
,
Junzhe Huang
,
Jiajia Zhao
,
Yu Yan
,
Min Xiao
,
Xueqin Song
,
Tony K C Hui
,
Zhong Zuo
,
William Ka-Kei Wu
,
Ho Ko
,
Kim Hei-Man Chow
,
Billy Wai-Lung Ng
· 0 min read
DOI
Abstract
Precise transformations of natural products (NPs) can fine-tune their physicochemical properties while preserving inherently complex and evolutionarily optimized parent scaffolds. Here, we report an unprecedented lactone-to-lactam transformation on bilobalide, thus improving its stability and paving the way for biological exploration of previously inaccessible chemical space that is highly representative of the parent structure. This late-stage molecular editing of bilobalide enables facile access to a unique library of lactam analogues with altered pharmacology. Through phenotypic screening, we identify BB10 as a hit compound with unexpected inhibition of ferroptotic cell death. We further reveal that BB10 suppresses ferroptosis by restoring the expression of glutathione peroxidase 4 (GPX4) in brain cells. This study highlights that even subtle changes on NP scaffolds can confer new pharmacological properties, inspiring the exploration of simple yet critical transformations on complex NPs.
Type
Publication
JACS Au 2024, 4, 9, 3537–3546
publications
Stephan Scheeff
Authors
Research Associate (Medicinal Chemistry)
Medicinal chemist designing novel antiviral and anticancer compounds. Researched nucleoside analogues at CUHK under Prof. Billy Ng since 2021, awarded Hong Kong Postdoctoral Fellowship 2022/2023. Enjoys exploring Hong Kong’s countryside and culture through photography.